Yesterday on October 5, 2021 at 1:30 pm, New York’s Cannabis Control Board (CCB) held its inaugural meeting. The meeting was broadcast live, with the recording and transcript of the meeting available here.
So what is the news coming out of the meeting? The short answer is that the CCB and the Office of Cannabis Management (OCM) are in the process of “staffing up” (some of which was formalized during the meeting) but are taking action to expand the medical cannabis program and cannabinoid hemp licensure immediately. Here are the highlights:
Expansion of the Medical Cannabis Program
Effective “immediately,” administration of New York’s medical cannabis program is being transitioned from the Department of Health (DOH) to the OCM. Practically, the OCM is taking the following actions (which go into effect immediately), which means that New York’s medical cannabis program is officially expanding:
Anyone who is legally allowed to prescribe a controlled substance can now prescribe cannabis under state law. The maximum supply of cannabis for patients is expanded to a 60 day supply (from a 30 day supply). Registered Organizations are allowed to sell whole flower to qualified patients. $50 registration fee for patients and caregivers is waived moving